PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Phase 2 Synovial Fluid Biomarker Study Update, page-2

  1. 2,143 Posts.
    lightbulb Created with Sketch. 576
    Well, they really trucked that up. Well and truly.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.